Regadenoson 55150-0443
Product NDC
55150-0443- Manufacturer
- Eugia Us Llc
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 26, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA216437
Need to source Regadenoson? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Regadenoson | .08 mg/mL |
Drug Class
Adenosine Receptor Agonist [EPC]Adenosine Receptor Agonists [MoA]Pharmacologic Cardiac Stress Test Agent [EPC]
Packaging Options(1)
1 SYRINGE in 1 CARTON (55150-443-01) / 5 mL in 1 SYRINGE